Knowledge graph · Drug
Thyrotropin Alfa
other
- Identifier
- CI-DRUG-00000782
- Entity page
- /drug/thyrotropin-alfa ↗
- Edges
- 15
- Neighbours
- 5 cancers1 genes5 trials4 approvals
- Drawn
- 15 of 15 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,147Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| Thyrotropin Alfa approved for …APPROVED_FOR8 of 4 | ||||||||
| → approved for | Malignant Thyroid Gland Neoplasmcancer | supports | FDA ORIG | Malignant Thyroid Gland Neoplasm | 1 | Regulatory | openfda | graph → |
| → approved for | Differentiated Thyroid Gland Carcinomasubtype | supports | ||||||